Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 28.48%839K | -272.76%-869K | 488.55%1.15M | 1,007.35%617K | 75.80%-242K | 169.83%653K | 335.05%503K | -132.85%-297K | -104.16%-68K | -138.73%-1M |
| Net profit before non-cash adjustment | -52.87%410K | -95.91%21K | 35.63%-421K | 86.13%-404K | 49.12%-1.13M | 122.51%870K | 183.55%513K | -41.56%-654K | -125.94%-2.91M | -131.34%-2.23M |
| Total adjustment of non-cash items | 31.71%785K | -83.45%91K | 314.94%331K | -16.78%3.14M | -24.08%2.15M | 256.89%596K | 376.38%550K | -115.78%-154K | 164.36%3.77M | 185.26%2.83M |
| -Depreciation and amortization | ---- | ---- | ---- | -19.09%992K | ---- | ---- | ---- | ---- | 3.37%1.23M | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --33K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Disposal profit | ---- | ---- | ---- | -183.28%-279K | ---- | ---- | ---- | ---- | 104.35%335K | ---- |
| -Other non-cash items | 31.71%785K | -83.45%91K | 314.94%331K | 8.23%2.39M | 10.58%1.4M | 256.89%596K | 376.38%550K | -115.78%-154K | 238.59%2.21M | -60.37%1.27M |
| Changes in working capital | 56.21%-356K | -75.18%-981K | 143.44%1.24M | -128.23%-2.12M | 21.55%-1.26M | -157.28%-813K | -193.49%-560K | 31.03%511K | 75.12%-928K | -32.64%-1.6M |
| -Change in receivables | ---- | ---- | ---- | -279.53%-2.1M | ---- | ---- | ---- | ---- | 87.25%-552K | ---- |
| -Change in inventory | ---- | ---- | ---- | -145.71%-634K | ---- | ---- | ---- | ---- | 231.22%1.39M | ---- |
| -Change in payables | ---- | ---- | ---- | 134.66%611K | ---- | ---- | ---- | ---- | -206.33%-1.76M | ---- |
| -Changes in other current assets | 1.16%870K | 86.02%-310K | 60.75%-429K | -215.15%-2.72M | -117.71%-271K | -28.03%860K | 33.74%-2.22M | -136.63%-1.09M | --2.36M | --1.53M |
| -Changes in other current liabilities | 26.72%-1.23M | -140.49%-671K | 4.30%1.67M | 130.75%551K | 36.46%-1.04M | -10.72%-1.67M | -58.00%1.66M | 161.84%1.6M | ---1.79M | ---1.63M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 25.00%-3K | 25.00%-3K | 40.00%-3K | 66.67%-2K | -8.33%11K | 20.00%-4K | 33.33%-4K | 28.57%-5K | 33.33%-6K | 12K |
| Interest received (cash flow from operating activities) | -46.73%106K | 0 | 116.30%199K | |||||||
| Tax refund paid | 0 | -138.46%-62K | -135.29%-40K | 31.62%-279K | -222.06%-219K | -17K | 87.25%-26K | 87.50%-17K | 62.67%-408K | 83.92%-68K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 32.28%836K | -297.46%-934K | 448.28%1.11M | 256.18%442K | 59.86%-344K | 166.67%632K | 211.56%473K | -141.92%-319K | -145.43%-283K | -138.16%-857K |
| Investing cash flow | ||||||||||
| Capital expenditures | -36.00%-272K | 0.55%-182K | -18.44%-212K | 36.07%-810K | 41.09%-248K | 45.65%-200K | 34.41%-183K | 10.05%-179K | -45.63%-1.27M | -492.96%-421K |
| Net PPE purchase and sale | --0 | --0 | --0 | 277.92%137K | 287.01%144K | --2K | --0 | ---9K | 75.40%-77K | ---77K |
| Net investment product transactions | ---- | ---- | ---- | -100.47%-7K | ---- | ---- | ---- | ---- | 198.40%1.49M | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | -12.50%7K | ---- | ---- | ---- | ---- | --8K | ---- |
| Investing cash flow | -37.37%-272K | 0.55%-182K | -12.77%-212K | -531.41%-673K | -110.38%-104K | 46.20%-198K | 34.41%-183K | 5.53%-188K | 122.84%156K | 763.79%1M |
| Financing cash flow | ||||||||||
| Increase or decrease of lease financing | 31.82%-15K | 286.96%43K | -286.96%-89K | 19.67%-147K | -38.60%-79K | 55.10%-22K | 41.03%-23K | 39.47%-23K | -10.24%-183K | 40.63%-57K |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | 29.17%-17K | ---- | ---- | ---- | ---- | -33.33%-24K | ---- |
| Financing cash flow | 31.82%-15K | 286.96%43K | -286.96%-89K | 20.77%-164K | -18.52%-96K | 55.10%-22K | 41.03%-23K | 39.47%-23K | 89.47%-207K | 95.73%-81K |
| Net cash flow | ||||||||||
| Beginning cash position | -73.85%290K | 61.88%1.36M | -59.69%553K | -26.05%948K | 17.00%1.52M | -25.07%1.11M | -62.11%842K | -19.20%1.37M | -65.57%1.28M | 5.61%1.3M |
| Current changes in cash | 33.25%549K | -501.87%-1.07M | 252.83%810K | -18.26%-395K | -950.00%-544K | 328.89%412K | 135.98%267K | -201.15%-530K | 83.51%-334K | -86.30%64K |
| End cash Position | -44.84%839K | -73.85%290K | 61.88%1.36M | -41.67%553K | -41.67%553K | 17.00%1.52M | -25.07%1.11M | -62.11%842K | -44.17%948K | -44.17%948K |
| Free cash flow | 29.95%564K | -484.83%-1.12M | 277.32%899K | 76.71%-379K | 56.01%-596K | 431.30%434K | 141.25%290K | -190.21%-507K | -190.54%-1.63M | -172.77%-1.36M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.